scholarly journals Phase 1 study of ipatasertib (AKT inhibitor) for investigating safety, tolerability, pharmacokinetics (PK), efficacy, and biomarkers in Japanese patients (pts) with solid tumors including castration-resistant prostate cancer (CRPC)

2017 ◽  
Vol 28 ◽  
pp. v131-v132
Author(s):  
S. Takahashi ◽  
Y. Fujiwara ◽  
N. Matsubara ◽  
J. Tomomatsu ◽  
S. Iwasa ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Solid Tumors ◽  
Phase 1 ◽  
Japanese Patients ◽  
Castration Resistant Prostate Cancer ◽  
Akt Inhibitor ◽  
Phase 1 Study ◽  
Castration Resistant

scholarly journals Phase‐1 study of abiraterone acetate in chemotherapy‐naïve Japanese patients with castration‐resistant prostate cancer

2014 ◽  
Vol 105 (10) ◽  
pp. 1313-1320 ◽  
Author(s):  
Nobuaki Matsubara ◽  
Hiroji Uemura ◽  
Iwao Fukui ◽  
Masashi Niwakawa ◽  
Akito Yamaguchi ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Phase 1 ◽  
Japanese Patients ◽  
Abiraterone Acetate ◽  
Castration Resistant Prostate Cancer ◽  
Phase 1 Study ◽  
Castration Resistant

Whole Blood Stem Cell Reinfusion and Escalated Dose Melphalan in Castration-Resistant Prostate Cancer: A Phase 1 Study

2012 ◽  
Vol 18 (8) ◽  
pp. 2352-2359 ◽  
Author(s):  
Jonathan Shamash ◽  
Jimmy Jacob ◽  
Samir Agrawal ◽  
Thomas Powles ◽  
Katherine Mutsvangwa ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Stem Cell ◽  
Whole Blood ◽  
Phase 1 ◽  
Blood Stem Cell ◽  
Castration Resistant Prostate Cancer ◽  
Phase 1 Study ◽  
Castration Resistant
Sign in / Sign up

Export Citation Format

Share Document